Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-147275

AGIOS PHARMACEUTICALS, INC. · AGIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Oct 26, 2016
Accepted (ET)
Oct 28, 2016 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001439222

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common stockF2Oct 26, 2016S627$48.91D108,405D
Common stockF2,F3Oct 26, 2016S625$48.91D108,443ISee footnote
Common stockF4Oct 27, 2016S627$48.97D107,778D
Common stockF4,F3Oct 27, 2016S625$48.97D107,818ISee footnote
Common stockF5holding———12,500ISee footnote
Common stockF6holding———12,500ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses